Quick Answer
Alpha-Lipoic Acid Exercise Recovery Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: This systematic review synthesized current evidence regarding the reversal of cardiovascular risk biomarkers after smoking cessation, with emphasis on the timing and magnitude of biomarker normalization.
Key Takeaways
- 01This systematic review synthesized current evidence regarding the reversal of cardiovascular risk biomarkers after smoking cessation, with emphasis on the timing and magnitude of biomarker normalization. [Mohammad A (2026)]
- 02Risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool and the Risk of Bias in Nonrandomized Studies-of Interventions (ROBINS-I) instrument, and findings were synthesized narratively because of methodological heterogeneity. [Mohammad A (2026)]
- 03Overall, smoking cessation was associated with progressive improvement in multiple cardiovascular risk pathways, supporting its critical role in cardiovascular prevention and highlighting the potential value of biomarker-guided approaches in future risk-reduction strategies. [Mohammad A (2026)]
- 04Cigarette smoking remains a major modifiable contributor to cardiovascular morbidity and mortality through mechanisms involving systemic inflammation, oxidative stress, endothelial dysfunction, dyslipidemia, and hematologic abnormalities. [Mohammad A (2026)]
The current Migaku evidence database contains 2 reusable source documents for Alpha-Lipoic Acid Exercise Recovery Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- This systematic review synthesized current evidence regarding the reversal of cardiovascular risk biomarkers after smoking cessation, with emphasis on the timing and magnitude of biomarker normalization. [Mohammad A (2026); evidence level 1]
- Risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool and the Risk of Bias in Nonrandomized Studies-of Interventions (ROBINS-I) instrument, and findings were synthesized narratively because of methodological heterogeneity. [Mohammad A (2026); evidence level 1]
- Overall, smoking cessation was associated with progressive improvement in multiple cardiovascular risk pathways, supporting its critical role in cardiovascular prevention and highlighting the potential value of biomarker-guided approaches in future risk-reduction strategies. [Mohammad A (2026); evidence level 1]
- Cigarette smoking remains a major modifiable contributor to cardiovascular morbidity and mortality through mechanisms involving systemic inflammation, oxidative stress, endothelial dysfunction, dyslipidemia, and hematologic abnormalities. [Mohammad A (2026); evidence level 1]
- This systematic review aimed to synthesize current clinical evidence on dietary supplementation for OS management in young adults undergoing intensive exercise and to evaluate study methodology critically. [Kakouris V (2026); evidence level 1]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources